The Actemra drug market is estimated to be valued at USD 3.796 Bn in 2024 and is expected to reach USD 6.7 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031. https://www.zupyak.com/p/4489724/t/actemra-drug-market-is-poised-for-high-growth-due-to-growing-prevalence-of-autoimmune-diseases